Table: Taiko Pharmaceutical - 9-MTH group results

Taiko Pharmaceutical

10/11/2023 06:30

Nov 10 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2023        Sep 30, 2022      Dec 31, 2023  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             4.42                3.39              6.40      
                 (+30.3 pct)                           (+27.0 pct)  
  Operating     loss 444 mln          loss 2.75       loss 800 mln  
  Recurring     loss 589 mln          loss 2.90         loss 1.00   
  Net                                                 loss 950 mln  
  Net           loss 562 mln          loss 3.18                     
  EPS          loss 12.09 yen      loss 72.97 yen    loss 20.42 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T